PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 26, 2016Circulation906 citations

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

View Full Paper
CYClyde W. YancyMJMariell JessupBBBiykem Bozkurt

Key Points

Key points are not available for this paper at this time.

Abstract

◼ angioedema ◼ angiotensin-converting enzyme inhibitors ◼ angiotensin receptor blockers ◼ angiotensin receptor

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yancy et al. (2016) studied this question. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are key pharmacological therapies updated in the 2016 ACC/AHA/HFSA guidelines for the management of heart failure.

synapsesocial.com/papers/6a0bd79cdc69176b05a940c0https://doi.org/10.1161/cir.0000000000000435
Ask AI
Helpful
Bookmark
Share
View Full Paper